 |
- Last updated refers to the date when our listing for each treatment was last updated.
- ID is our internal ID - starting with VT.
- Min Karnofsky is a general guide to how well you have to function to use this treatment
- For trials that also have a NCT number, you can click that number to pop up the listing from the clinicaltrials.gov website.
 |
 |
 |
 |
 |
 |
Treatment Name: |
 |
Lonafarnib and Temozolomide in Treating Patients With Recurrent Primary Supratentorial Gliomas |
 |
 |
 |
 |
 |
 |
Keywords: |
 |
Temodar, Lonafarnib |
 |
 |
 |
 |
Phase: |
 |
Phase 1 |
 |
 |
 |
 |
 |
 |
Treatment ID#s: |
 |
VT1656
NCT00083096
|
 |
 |
 |
 |
Age Group: |
 |
Adults Only |
 |
 |
 |
 |
 |
 |
Min Karnofsky Score: |
 |
Not Specified |
 |
 |
 |
 |
Conditions: |
 |
Newly Diagnosed: N
Recurrent: Y
Prior Surgery is Allowed Prior Radiation is Allowed Prior Chemotherapy is Allowed |
 |
 |
 |
 |
 |
 |
Last Updated: |
 |
11/27/2005 |
 |
 |
 |
 |
Tumor Types: |
 |
Anaplastic Astrocytoma Ependyoma Glioblastoma Multiforme Mixed Glioma Oligodendroglioma High Grade |
 |
 |
 |
 |
 |
 |
 |
Comments: |
 |
|
 |
 |
 |
 |
 |
 |
Treatment Type: |
 |
Chemotherapy. |
 |
 |
 |
 |
Contact: |
 |
Centre Hospitalier Universitaire Vaudois Roger Stupp, MD Lausanne, CH-1011 Switzerland Phone:41-21-314-0156 Email not available |
 |
 |
|
|